A novel Ca²+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension-Reference-Cited by-同舟云学术

A novel Ca²+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension

Published:2013-02 Issue:1-3 Volume:702 Page:316-322
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Pereira Sharlene Lopes,Kummerle Arthur Eugen,Fraga Carlos Alberto Manssour,Barreiro Eliezer Jesus,Rocha Nazareth de Novaes,Ferraz Emanuelle Baptista,Nascimento José Hamilton Matheus do,Sudo Roberto Takashi,Zapata-Sudo Gisele

Funder

Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Fundação Universitária Jose Bonifácio (FUJB)

PRONEX, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)

Instituto Nacional de Ciência e Tecnologia (INCT)

Publisher

Elsevier BV

Subject

Pharmacology

Reference35 articles.

1. New perspectives for the treatment of pulmonary hypertension;Baliga;Br. J. Pharmacol.,2010

2. Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells;Block;Proc. Natl. Acad. Sci.,1989

3. Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension;Bonnet;Pharmacol. Ther.,2007

4. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension;Christman;N. Engl. J. Med.,1992

5. Nitric oxide and endothelin-1 in pulmonary hypertension;Giaid;Chest,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low Thyroid Hormones Level Attenuates Mitochondrial Dysfunction and Right Ventricular Failure in Pulmonary Hypertensive Rats;Cardiovascular Drugs and Therapy;2024-08-31

2. The Thin Line between Promiscuous and Privileged Structures in Medicinal Chemistry;Journal of the Brazilian Chemical Society;2024

3. The CaMKII phosphorylation site Thr1604 in the CaV1.2 channel is involved in pathological myocardial hypertrophy in rats;Channels;2020-01-01

4. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension;Archives of Cardiovascular Diseases;2020-01

5. Efficacy of stem cell therapy for pulmonary arterial hypertension: a systematic review and meta-analysis of preclinical studies;Stem Cell Research & Therapy;2019-02-13